Deutsche Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.15M | Sell |
367,415
-13,940
| -4% | -$195K | ﹤0.01% | 1217 |
|
|
2025
Q1 | $5.96M | Sell |
381,355
-6,181
| -2% | -$96.7K | ﹤0.01% | 1177 |
|
|
2024
Q4 | $5.4M | Sell |
387,536
-412,491
| -52% | -$5.75M | ﹤0.01% | 1289 |
|
|
2024
Q3 | $7.44M | Sell |
800,027
-1,081,998
| -57% | -$10.1M | ﹤0.01% | 1114 |
|
|
2024
Q2 | $17.5M | Buy |
1,882,025
+9,420
| +0.5% | +$87.6K | 0.01% | 848 |
|
|
2024
Q1 | $18.6M | Buy |
1,872,605
+478,195
| +34% | +$4.74M | 0.01% | 831 |
|
|
2023
Q4 | $4.5M | Buy |
1,394,410
+1,364,048
| +4,493% | +$4.41M | ﹤0.01% | 1288 |
|
|
2023
Q3 | $161K | Buy |
30,362
+3,655
| +14% | +$19.4K | ﹤0.01% | 2894 |
|
|
2023
Q2 | $255K | Sell |
26,707
-9,586
| -26% | -$91.4K | ﹤0.01% | 2745 |
|
|
2023
Q1 | $399K | Buy |
36,293
+11,121
| +44% | +$122K | ﹤0.01% | 2619 |
|
|
2022
Q4 | $373K | Buy |
25,172
+6,968
| +38% | +$103K | ﹤0.01% | 2597 |
|
|
2022
Q3 | $348K | Buy |
18,204
+555
| +3% | +$10.6K | ﹤0.01% | 2593 |
|
|
2022
Q2 | $376K | Buy |
17,649
+2,458
| +16% | +$52.4K | ﹤0.01% | 2756 |
|
|
2022
Q1 | $293K | Sell |
15,191
-1,778
| -10% | -$34.3K | ﹤0.01% | 3033 |
|
|
2021
Q4 | $352K | Buy |
16,969
+882
| +5% | +$18.3K | ﹤0.01% | 3023 |
|
|
2021
Q3 | $384K | Sell |
16,087
-1,946
| -11% | -$46.5K | ﹤0.01% | 3185 |
|
|
2021
Q2 | $492K | Buy |
18,033
+1,428
| +9% | +$39K | ﹤0.01% | 3211 |
|
|
2021
Q1 | $480K | Sell |
16,605
-99,330
| -86% | -$2.87M | ﹤0.01% | 3115 |
|
|
2020
Q4 | $3.26M | Buy |
115,935
+106,120
| +1,081% | +$2.98M | ﹤0.01% | 1595 |
|
|
2020
Q3 | $288K | Buy |
9,815
+5,090
| +108% | +$149K | ﹤0.01% | 2959 |
|
|
2020
Q2 | $143K | Buy |
4,725
+1,067
| +29% | +$32.3K | ﹤0.01% | 3240 |
|
|
2020
Q1 | $109K | Buy |
+3,658
| New | +$109K | ﹤0.01% | 3162 |
|